|
1.
|
Kuvin JT, Patel AR, Sliney KA, Pandian NG,
Rand WM, Udelson JE and Karas RH: Peripheral vascular endothelial
function testing as a noninvasive indicator of coronary artery
disease. J Am Coll Cardiol. 38:1843–1849. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Heitzer T, Schlinzig T, Krohn K, Meinertz
T and Munzel T: Endothelial dysfunction, oxidative stress, and risk
of cardiovascular events in patients with coronary artery disease.
Circulation. 104:2673–2678. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Faxon DP, Fuster V, Libby P, Beckman JA,
Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi
RP, Robertson RM and Loscalzo J: American Heart Association.
Atherosclerotic vascular disease conference: writing group III:
pathophysiology. Circulation. 109:2617–2625. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Puddu P, Cravero E, Puddu GM and Muscari
A: Genes and atherosclerosis: at the origin of the predisposition.
Int J Clin Pract. 59:462–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Wolf A, Zalpour C, Theilmeier G, Wang BY,
Ma A, Anderson B, Tsao PS and Cooke JP: Dietary l-arginine
supplementation normalizes platelet aggregation in
hypercholesterolemic humans. J Am Coll Cardiol. 29:479–485. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kubes P, Suzuki M and Granger DN: Nitric
oxide: an endogenous modulator of leukocyte adhesion. Proc Natl
Acad Sci USA. 88:4651–4655. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Garg UC and Hassid A: Nitric
oxide-generating vasodilators and 8-bromo-cyclic guanosine
monophosphate inhibit mitogenesis and proliferation of cultured rat
vascular smooth muscle cells. J Clin Invest. 83:1774–1777. 1989.
View Article : Google Scholar
|
|
8.
|
Böger RH, Bode-Böger SM, Mügge A, Kienke
S, Brandes R, Dwenger A and Frölich JC: Supplementation of
hypercholesterolaemic rabbits with L-arginine reduces the vascular
release of superoxide anions and restores NO production.
Atherosclerosis. 117:273–284. 1995.PubMed/NCBI
|
|
9.
|
Hogg N, Kalyanaraman B, Joseph J, Struck A
and Parthasarathy S: Inhibition of low-density lipoprotein
oxidation by nitric oxide. Potential role in atherogenesis. FEBS
Lett. 334:170–174. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wilcox JN, Subramanian RR, Sundell CL,
Tracey WR, Pollock JS, Harrison DG and Marsden PA: Expression of
multiple isoforms of nitric oxide synthase in normal and
atherosclerotic vessels. Arterioscler Thromb Vasc Biol.
17:2479–2488. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Nakayama M, Yasue H, Yoshimura M,
Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y,
Miyamoto Y and Nakao K: T-786-->C mutation in the 5′-flanking
region of the endothelial nitric oxide synthase gene is associated
with coronary spasm. Circulation. 99:2864–2870. 1999.
|
|
12.
|
Yoshimura M, Yasue H, Nakayama M,
Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y,
Saito Y, Miyamoto Y and Nakao K: A missense Glu298Asp variant in
the endothelial nitric oxide synthase gene is associated with
coronary spasm in the Japanese. Hum Genet. 103:65–69. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Wang XL, Sim AS, Badenhop RF, McCredie RM
and Wilcken DE: A smoking-dependent risk of coronary artery disease
associated with a polymorphism of the endothelial nitric oxide
synthase gene. Nat Med. 2:41–45. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Casas JP, Cavalleri GL, Bautista LE,
Smeeth L, Humphries SE and Hingorani AD: Endothelial nitric oxide
synthase gene polymorphisms and cardiovascular disease: a HuGE
review. Am J Epidemiol. 164:921–935. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pieper GM: Review of alterations in
endothelial nitric oxide production in diabetes: protective role of
arginine on endothelial dysfunction. Hypertension. 31:1047–1060.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Wilson PW: Established risk factors and
coronary artery disease: the Framingham Study. Am J Hypertens.
7:S7–S12. 1994.PubMed/NCBI
|
|
17.
|
Chobanian AV, Bakris GL, Black HR, Cushman
WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright
JT Jr and Roccella EJ: The seventh report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure: the JNC 7 report. JAMA. 289:2560–2572. 2003.
View Article : Google Scholar
|
|
18.
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 27:S5–S9.
2004. View Article : Google Scholar
|
|
19.
|
Wang XL, Mahaney MC, Sim AS, Wang J, Wang
J, Blangero J, Almasy L, Badenhop RB and Wilcken DE: Genetic
contribution of the endothelial constitutive nitric oxide synthase
gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol.
17:3147–3153. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Cooke JP: Role of nitric oxide in
progression and regression of atherosclerosis. West J Med.
164:419–424. 1996.PubMed/NCBI
|
|
21.
|
Tesauro M, Thompson WC, Rogliani P, Qi L,
Chaudhary PP and Moss J: Intracellular processing of endothelial
nitric oxide synthase isoforms associated with differences in
severity of cardiopulmonary diseases: cleavage of proteins with
aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA.
97:2832–2835. 2000. View Article : Google Scholar
|
|
22.
|
Kim IJ, Bae J, Lim SW, Cha DH, Cho HJ, Kim
S, Yang DH, Hwang SG, Oh D and Kim NK: Influence of endothelial
nitric oxide synthase gene polymorphisms (-786T>C, 4a4b,
894G>T) in Korean patients with coronary artery disease. Thromb
Res. 119:579–585. 2007.
|
|
23.
|
McVeigh GE, Brennan GM, Johnston GD,
McDermott BJ, McGrath LT, Henry WR, Andrews JW and Hayes JR:
Impaired endothelium-dependent and independent vasodilation in
patients with type 2 (non-insulin-dependent) diabetes mellitus.
Diabetologia. 35:771–776. 1992.PubMed/NCBI
|
|
24.
|
Zhang C, Lopez-Ridaura R, Hunter DJ, Rifai
N and Hu FB: Common variants of the endothelial nitric oxide
synthase gene and the risk of coronary heart disease among US
diabetic men. Diabetes. 55:2140–2147. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Pulkkinen A, Viitanen L, Kareinen A, Lehto
S, Vauhkonen I and Laakso M: Intron 4 polymorphism of the
endothelial nitric oxide synthase gene is associated with elevated
blood pressure in type 2 diabetic patients with coronary heart
disease. J Mol Med. 78:372–379. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ksiazek P, Wojewoda P, Muc K and
Buraczynska M: Endothelial nitric oxide synthase gene intron 4
polymorphism in type 2 diabetes mellitus. Mol Diagn. 7:119–123.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Monti LD, Barlassina C, Citterio L,
Galluccio E, Berzuini C, Setola E, Valsecchi G, Lucotti P, Pozza G,
Bernardinelli L, Casari G and Piatti P: Endothelial nitric oxide
synthase polymorphisms are associated with type 2 diabetes and the
insulin resistance syndrome. Diabetes. 52:1270–1275. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Rittig K, Holder K, Stock J, Tschritter O,
Peter A, Stefan N, Fritsche A, Machicao F, Häring HU and
Balletshofer B: Endothelial NO-synthase intron 4 polymorphism is
associated with disturbed in vivo nitric oxide production in
individuals prone to type 2 diabetes. Horm Metab Res. 40:13–17.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Lee JE, Choi JH, Lee JH and Lee MG: Gene
SNPs and mutations in clinical genetic testing: haplotype-based
testing and analysis. Mutat Res. 573:195–204. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Rios DL, Callegari-Jacques SM and Hutz MH:
Endothelial nitric oxide synthase and fractalkine chemokine
receptor polymorphisms on angiographically assessed coronary
atherosclerosis. Clin Chim Acta. 362:138–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Rios DL, D’Onofrio LO, Souza JK, Queiroz
AM, Raduy-Maron L, Silva-Neto N, Carvalho HG, Santos-Filho A and
Galvão-Castro B: Smoking-dependent and haplotype-specific effects
of endothelial nitric oxide synthase gene polymorphisms on
angiographically assessed coronary artery disease in Caucasian- and
African-Brazilians. Atherosclerosis. 193:135–141. 2007. View Article : Google Scholar
|
|
32.
|
Sandrim VC, de Syllos RW, Lisboa HR, Tres
GS and Tanus-Santos JE: Endothelial nitric oxide synthase
haplotypes affect the susceptibility to hypertension in patients
with type 2 diabetes mellitus. Atherosclerosis. 189:241–246. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Sandrim VC, de Syllos RW, Lisboa HR, Tres
GS and Tanus-Santos JE: Influence of eNOS haplotypes on the plasma
nitric oxide product concentrations in hypertensive and type 2
diabetes mellitus patients. Nitric Oxide. 16:348–355. 2007.
View Article : Google Scholar : PubMed/NCBI
|
